EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
10h
Hosted on MSNShould You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...
Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today ...
The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.
Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial ...
Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.
11d
What to Expect on MSNShould You Get the COVID-19 Vaccine for Your Baby or Toddler?Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.
Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Other fact-checking organizations have debunked the claim; Reuters and AFP have also fact-checked similar claims that circulated in 2022 and 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results